|
Real-time Estimate
Cboe BZX
20:59:16 27/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 812.91 USD | -0.23% |
|
-1.61% | +5.37% |
| 10:48am | AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial | RE |
| 08-25 | Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Biopharmaceuticals | -0.29% | -1.61% | +5.37% | +38.57% | +22.62% | 81.36B |  | | |
- Stock Market
- Stocks
- REGN Stock
- Charts Regeneron Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
